Novozymes A/S (NZM2.SG)
- Previous Close
58.50 - Open
58.16 - Bid 58.68 x 50000
- Ask 59.02 x 50000
- Day's Range
58.16 - 58.22 - 52 Week Range
50.10 - 64.92 - Volume
0 - Avg. Volume
99 - Market Cap (intraday)
17.489B - Beta (5Y Monthly) --
- PE Ratio (TTM)
40.26 - EPS (TTM)
1.45 - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. It operates through three divisions: Household Care and Technical Industries, Agriculture and Bioenergy, and Food and Beverages. The company offers solutions for the agriculture industry, including enzymes for animal nutrition to enhance digestion processes; probiotics; microbial solutions to maintain water quality that limits risk of disease and enhances yields in aquaculture; and microbial-based biocontrol and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; enzymes for drug delivery and drug formulation; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and biological wastewater treatment products. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
www.novozymes.com6,385
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: NZM2.SG
View MorePerformance Overview: NZM2.SG
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NZM2.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NZM2.SG
View MoreValuation Measures
Market Cap
27.25B
Enterprise Value
28.70B
Trailing P/E
59.09
Forward P/E
28.99
PEG Ratio (5yr expected)
0.25
Price/Sales (ttm)
6.76
Price/Book (mrq)
2.43
Enterprise Value/Revenue
7.07
Enterprise Value/EBITDA
34.98
Financial Highlights
Profitability and Income Statement
Profit Margin
20.90%
Return on Assets (ttm)
13.79%
Return on Equity (ttm)
26.46%
Revenue (ttm)
2.12B
Net Income Avi to Common (ttm)
443.42M
Diluted EPS (ttm)
1.45
Balance Sheet and Cash Flow
Total Cash (mrq)
107.64M
Total Debt/Equity (mrq)
16.85%
Levered Free Cash Flow (ttm)
232.8M